Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch

Mumbai-based Cipla faces massive income tax demand of ₹774 crore over rule violations, including short deductions and disallowance of expenses, amid the launch of its new obesity drug.

CiplaIncome Tax DemandRule ViolationsObesity DrugPharmaceutical IndustryReal Estate MumbaiJul 16, 2024

Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch
Real Estate Mumbai:Cipla, a leading pharmaceutical company based in Mumbai, has been handed a massive income tax demand of ₹774 crore. The demand notice cites additional taxes for rule violations, including short deductions, weighted deductions, and disallowance of expenses. This development comes at a time when the company is preparing to launch a new obesity drug.

The income tax demand of ₹773.44 crore covers assessment years from 2015-16 to 2022-23, excluding any tax refunds. Cipla has confirmed the demand in its regulatory filings and plans to appeal against the tax order. The company has stated that the tax demands are not applicable under the law.

The tax authorities have cited rule violations, including short deductions, wherein the company deducted less tax than the rate mentioned in the provisions. Additionally, weighted deductions allowed for companies to invest in the development of knowledge and research capabilities were also disallowed, as well as expenses incurred for business operations.

Cipla is a well-established pharmaceutical company that has been operating in India for over 80 years. The company has a strong presence in the domestic market and exports its products to over 80 countries worldwide. Despite the income tax demand, Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally.

Information
Cipla is an Indian multinational pharmaceutical company that was founded in 1935. The company is headquartered in Mumbai and has a strong presence in the domestic market. Cipla is known for its innovative and affordable healthcare solutions and has a global footprint, with exports to over 80 countries.

Cipla is a leading pharmaceutical company that has been operating in India for over 80 years. The company is committed to providing innovative and affordable healthcare solutions to patients globally.

Frequently Asked Questions

What is the amount of income tax demand slapped on Cipla?

The income tax demand on Cipla is ₹774 crore.

What are the rule violations cited by the tax authorities?

The tax authorities have cited rule violations, including short deductions, weighted deductions, and disallowance of expenses.

What is Cipla's response to the income tax demand?

Cipla has stated that the tax demands are not applicable under the law and plans to appeal against the tax order.

What is the significance of the income tax demand on Cipla?

The income tax demand on Cipla is significant as it comes at a time when the company is preparing to launch a new obesity drug, and may impact its financial performance.

What is Cipla's commitment to its customers?

Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally, despite the income tax demand.

Related News Articles

Two Injured in Pimpri Chinchwad as Speeding Pickup Truck Hits Divider
Real Estate Pune

Two Injured in Pimpri Chinchwad as Speeding Pickup Truck Hits Divider

The incident occurred at around 10:45 pm on Wednesday, and the injured people have been admitted to the hospital for treatment.

August 8, 2024
Read Article
Luxury Housing Market Surges 28% in Q1 2025 Across Major Indian Cities
Real Estate Pune

Luxury Housing Market Surges 28% in Q1 2025 Across Major Indian Cities

A recent report by Grihum Housing Finance highlights a significant 28% growth in the luxury housing sector during Q1 2025, driven by the emergence of micro-markets across key cities like Delhi-NCR, Mumbai, and Bangalore.

April 17, 2025
Read Article
Top Investment Themes for 2025: A Comprehensive Guide
real estate news

Top Investment Themes for 2025: A Comprehensive Guide

Explore the most promising investment themes for 2025, covering sectors like real estate, stocks, and more. Stay ahead of the market trends and make informed decisions.

December 22, 2024
Read Article
Navigating 2024 Budget Reforms: Understanding Real Estate Capital Gains Tax Changes
real estate news

Navigating 2024 Budget Reforms: Understanding Real Estate Capital Gains Tax Changes

Discover how the revised Short Term and Long Term Capital Gains tax rates affect your real estate investments.

July 25, 2024
Read Article
Stocks in Focus: Titan, Swiggy, Tata Power, Aadhaar Housing, and Whirlpool
real estate news

Stocks in Focus: Titan, Swiggy, Tata Power, Aadhaar Housing, and Whirlpool

Several prominent companies, including Titan, Swiggy, Tata Power, Aadhaar Housing, and Whirlpool, are expected to be in the spotlight ahead of the market opening. Here's a detailed look at their recent performance and upcoming events.

February 5, 2025
Read Article
Real Estate Developers Gear Up for Major H2 FY25 Launches
real estate news

Real Estate Developers Gear Up for Major H2 FY25 Launches

Following a slow first half, Indian real estate developers, including major Bengaluru players like Prestige, Puravankara, Sobha, and Brigade, are preparing for a flurry of project launches in the second half of the financial year 2025.

November 27, 2024
Read Article